Aquatic Capital Management LLC Grifols Sa Transaction History

Aquatic Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$7.71 - $11.56 $310,713 - $465,868	40,300 Added 463.22%	49,000 $566,000
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $72,171 - $88,371	8,100 Added 1350.0%	8,700 $80,000
Q2 2023 Aug 14, 2023	BUY	$7.14 - $9.29 $4,284 - $5,573	600 New	600 $5,000
Q3 2022 Nov 14, 2022	BUY	$5.95 - $14.3 $461,720 - $1.11 Million	77,600 New	77,600 $478,000
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $54,960 - $67,469	-5,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $54,113 - $80,931	5,300 New	5,300 $60,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.